CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Millions		Jun. 30, 2022	Sep. 30, 2021
Current assets
Cash and cash equivalents		$ 629	$ 210
Accounts receivable - Note H	[1]	488	369
Inventories - Note F		609	473
Other assets		91	68
Current assets held for sale - Note B		0	597
Total current assets		1,817	1,717
Property, plant and equipment
Cost		3,065	3,066
Accumulated depreciation		1,713	1,639
Net property, plant and equipment		1,352	1,427
Goodwill - Note G		1,356	1,430
Intangibles - Note G		1,001	1,099
Operating lease assets, net - Note I		112	124
Restricted investments - Note E		346	384
Asbestos insurance receivable - Note L	[2]	140	134
Deferred income taxes		30	30
Other assets		258	267
Total noncurrent assets		4,595	4,895
Total assets		6,412	6,612
Current liabilities
Short-term debt - Note H		0	365
Current portion of long-term debt - Note H		0	9
Trade and other payables		241	236
Accrued expenses and other liabilities		291	251
Current operating lease obligations - Note I		18	23
Current liabilities held for sale - Note B		0	50
Total current liabilities		550	934
Noncurrent liabilities
Long-term debt - Note H		1,302	1,596
Asbestos litigation reserve - Note L		483	490
Deferred income taxes		218	237
Employee benefit obligations - Note K		137	144
Operating lease obligations - Note I		100	110
Other liabilities		356	349
Total noncurrent liabilities		2,596	2,926
Commitments and contingencies - Note L
Stockholders' equity - Note N		3,266	2,752
Total liabilities and stockholders' equity		$ 6,412	$ 6,612

[1] Accounts receivable includes an allowance for credit losses of $2 million at both June 30, 2022 and September 30, 2021.

[2] Asbestos insurance receivable includes an allowance for credit losses of $3 million at both June 30, 2022 and September 30, 2021.